CCA
WGSWW

Castle Creek Arbitrage’s GeneDx Holdings Warrant WGSWW Stock Holding History

Castle Creek Arbitrage’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19,632
Closed -$54K – 572
2020
Q4 		$54K Buy
+19,632
New +$49.4K ﹤0.01% 273

Other funds holding WGSWW

SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Castle Creek Arbitrage's WGSWW Position: Q1 2021 in Review

Castle Creek Arbitrage sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2021, closing a stake of 19,632 shares — an estimated $54K sold.

Castle Creek Arbitrage first reported a position in WGSWW in Q4 2020 and held it in 1 quarter. The position peaked at $54K in Q4 2020. 28 funds tracked by Wall St. Rank hold WGSWW as of Q1 2021.

  • Castle Creek Arbitrage reported no remaining GeneDx Holdings Warrant position as of Q1 2021 after selling out during the quarter.
  • Castle Creek Arbitrage sold 19,632 GeneDx Holdings Warrant shares in Q1 2021, an estimated $54K.
  • Castle Creek Arbitrage first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 1 quarter.
  • Castle Creek Arbitrage's GeneDx Holdings Warrant position peaked at $54K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2021.

Based on Castle Creek Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.